Associations of childhood adiposity with adult intima–media thickness and inflammation: a 20-year longitudinal population-based cohort

Background: The associations between childhood adiposity and adult increased carotid intima–media thickness (cIMT) have been well established, which might be corroborated by the association between adiposity in children and inflammation in adults. However, longitudinal data regarding biological pathways associated with childhood adiposity are lacking. Methods: The current study included participants from the STANISLAS cohort who had adiposity measurements at age 5–18 years [N = 519, mean (SD) age, 13.0 (2.9) years; 46.4% male], and who were measured with cIMT, vascular-related and metabolic-related proteins at a median follow-up of 19 ± 2 years. BMI, waist-to-height ratio and waist circumference were converted to age-specific and sex-specific z-scores. Results: A minority of children were overweight/obese (16.2% overweight-BMI z-score >1; 1.3% obesity-z-score >2). Higher BMI, waist–height ratio and waist circumference in children were significantly associated with greater adult cIMT in univariable analysis, although not after adjusting for C-reactive protein. These associations were more pronounced in those with consistently high adiposity status from childhood to middle adulthood. Participants with higher adiposity during childhood (BMI or waist–height ratio) had higher levels of insulin-like growth factor-binding protein-1, protein-2, matrix metalloproteinase-3, osteopontin, hemoglobin and C-reactive protein in adulthood. Network analysis showed that IL-6, insulin-like growth factor-1 and fibronectin were the key proteins associated with childhood adiposity. Conclusion: In a population-based cohort followed for 20 years, higher BMI or waist-to-height ratio in childhood was significantly associated with greater cIMT and enhanced levels of proteins reflective of inflammation, supporting the importance of inflammation as progressive atherosclerosis in childhood adiposity.

[1]  M. Domingo,et al.  Biomarkers in Heart Failure with Preserved Ejection Fraction , 2022, Cardiac failure review.

[2]  P. Ridker,et al.  Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease , 2021, Circulation research.

[3]  A. Ba-Ssalamah,et al.  Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients , 2021, International Journal of Obesity.

[4]  Chiadi E. Ndumele,et al.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.

[5]  M. Schwartz,et al.  Fibronectin‐Mediated Inflammatory Signaling Through Integrin α5 in Vascular Remodeling , 2021, bioRxiv.

[6]  S. Heymans,et al.  Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. , 2020, JACC. Heart failure.

[7]  OUP accepted manuscript , 2021, Cardiovascular Research.

[8]  E. Blaak,et al.  Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver , 2020, Nature Reviews Endocrinology.

[9]  P. Jagodziński,et al.  Association of rs699947 (−2578 C/A) and rs2010963 (−634 G/C) Single Nucleotide Polymorphisms of the VEGF Gene, VEGF-A and Leptin Serum Level, and Cardiovascular Risk in Patients with Excess Body Mass: A Case–Control Study , 2020, Journal of clinical medicine.

[10]  M. Devignes,et al.  Insulin-like growth factor binding protein 2: A prognostic biomarker for heart failure hardly redundant with natriuretic peptides. , 2019, International journal of cardiology.

[11]  R. Vettor,et al.  The Endothelium in Acromegaly , 2019, Front. Endocrinol..

[12]  N. Faucheux,et al.  Effect of BMP-9 on endothelial cells and its role in atherosclerosis. , 2019, Frontiers in bioscience.

[13]  Stefan Konigorski,et al.  Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. , 2019, Metabolism: clinical and experimental.

[14]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[15]  F. Zannad,et al.  Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort , 2018, Journal of hypertension.

[16]  T. Lehtimäki,et al.  Distinct child-to-adult body mass index trajectories are associated with different levels of adult cardiometabolic risk , 2018, European heart journal.

[17]  K. Reue,et al.  Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes? , 2018, Molecular metabolism.

[18]  Stefan Enroth,et al.  Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases , 2018, Scientific Reports.

[19]  F. Zannad,et al.  Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. , 2018, International journal of epidemiology.

[20]  Henning Hermjakob,et al.  Reactome graph database: Efficient access to complex pathway data , 2018, PLoS Comput. Biol..

[21]  D. Mozaffarian,et al.  Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk. , 2018, Clinical chemistry.

[22]  H. Parving,et al.  Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies , 2017, Cardiovascular Diabetology.

[23]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[24]  M. Netea,et al.  IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. , 2017, Journal of molecular endocrinology.

[25]  A. Leite-Moreira,et al.  Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus. , 2016, International journal of cardiology.

[26]  S. Hadjiyannakis,et al.  LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5–19 y in NHANES III: association with cardio-metabolic risks , 2015, Pediatric Research.

[27]  P. Whincup,et al.  Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60-64 years in the 1946 British birth cohort study: an epidemiological study. , 2014, The lancet. Diabetes & endocrinology.

[28]  T. Lehtimäki,et al.  Prospective Relationship of Change in Ideal Cardiovascular Health Status and Arterial Stiffness: The Cardiovascular Risk in Young Finns Study , 2014, Journal of the American Heart Association.

[29]  D. Lawlor,et al.  Childhood obesity and vascular phenotypes: a population study. , 2012, Journal of the American College of Cardiology.

[30]  T. Cole,et al.  Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity , 2012, Pediatric obesity.

[31]  Jos W. M. van der Meer,et al.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.

[32]  L. Folkersen,et al.  The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. , 2012, Atherosclerosis.

[33]  Terence Dwyer,et al.  Childhood adiposity, adult adiposity, and cardiovascular risk factors. , 2011, The New England journal of medicine.

[34]  C. Dinarello,et al.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.

[35]  J. Floras,et al.  Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. , 2010, Journal of the American College of Cardiology.

[36]  Terho Lehtimäki,et al.  Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.

[37]  L. Ghiadoni,et al.  Osteopontin Is Associated with Increased Arterial Stiffness in Rheumatoid Arthritis , 2009, Molecular medicine.

[38]  P. Libby,et al.  Obesity, inflammation, and atherosclerosis , 2009, Nature Reviews Cardiology.

[39]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[40]  J. Polak,et al.  Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  A. Ferrante,et al.  Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation , 2007, Journal of internal medicine.

[42]  E. Barrett-Connor,et al.  Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study). , 2007, The American journal of cardiology.

[43]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[44]  C. Papamichael,et al.  Impact of Obesity in Intima Media Thickness of Carotid Arteries , 2006, Obesity.

[45]  J. Ruidavets,et al.  Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1 , 2006, Journal of hypertension.

[46]  T. Lobstein,et al.  Worldwide trends in childhood overweight and obesity. , 2006, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.

[47]  C. Papamichael,et al.  Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. , 2005, The Journal of pediatrics.

[48]  Yasmin,et al.  Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[50]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[51]  J. Dawson,et al.  Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study , 2001, Circulation.

[52]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.

[53]  M. Safar,et al.  Influence of body height on pulsatile arterial hemodynamic data. , 1998, Journal of the American College of Cardiology.

[54]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[55]  R. Hruban,et al.  Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. , 1992, The American journal of cardiology.

[56]  J. Salonen,et al.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[57]  O. de Divitiis,et al.  Obesity and Cardiac Function , 1981, Circulation.

[58]  G. Schwartz,et al.  A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine , 1976, Pediatrics.